Broadcom: The Market Has Priced In An OpenAI Collapse, Not An Anthropic One

Broadcom is rated Buy, with the article arguing the market has already priced in a potential OpenAI collapse and that AVGO has upside if those risks do not materialize. AI contributes over 50% of revenue, and the article says earnings remain robust even if Broadcom loses OpenAI or Anthropic halves its orders; estimated 2028 P/E multiples under these stress scenarios range from 11x to 19x.

Analysis

The key risk is not a binary OpenAI failure but buyer power: hyperscalers can redirect or renegotiate accelerator programs, making AVGO’s growth and pricing more sensitive to a few large customers than headline AI demand implies. Alphabet is a meaningful two-sided exposure: its demand can support AVGO, while its incentive to control silicon economics may strengthen its leverage over suppliers. Over time, broader custom-silicon adoption could also pressure merchant accelerator and networking vendors, though execution and substitution timelines matter.

The bullish asymmetry depends on the market having already discounted customer disruption; the article provides no valuation date, consensus estimates, or evidence for that pricing claim. A lower forward multiple in a stress case is not itself downside protection if earnings estimates or the multiple reset further. Near term, watch AVGO guidance and customer/program commentary; over 1–3 months, order revisions and hyperscaler capex plans are more informative than AI announcements. Over 6–18 months, customer concentration, program ramps, and pricing are the structural tests. The thesis weakens materially if guidance cuts reveal lost or delayed programs, or if hyperscaler spending slows broadly. No high-conviction trade follows without current valuation and expectations data.

Key Decisions for Investors

• Keep AVGO on a conditional long watchlist rather than chase the bullish narrative. Before entry, verify current valuation versus forward earnings, consensus revisions, and how much customer disruption is already embedded in the share price.
• For an existing AVGO position, size against concentrated-customer and program-ramp risk; reassess on guidance or order commentary rather than treating OpenAI-related stress scenarios as proof of a floor.
• Monitor Alphabet’s capex and custom-silicon disclosures alongside AVGO’s networking and semiconductor guidance. Strong Alphabet spending with stable AVGO program commentary supports the thesis; lower spend or evidence of supplier substitution falsifies it.
• Avoid an AVGO-versus-GOOG pair absent evidence of relative earnings or valuation divergence: the same hyperscaler demand cycle can affect both, while the article does not establish the magnitude or timing of either company’s exposure.